Category Archives: Genetic Therapy

MORGELLONS HORROR SHOW 11: HAIR FOLLICLE GENE THERAPY CREATES DISEASED HAIR – Video

15-05-2011 21:54 Correction: 3:11-The blue hair may get its color from fluorescent bacteria or fungus inside the hair shaft. Mites can deliver bacteria which have uptook gene changing products. Bacteria can deliver DNA, nanoparticles to hair follicles Continue reading →

Posted in Genetic Therapy | Tagged a-which-have, bacteria-which, birmingham, delivery, DNA, fungus-inside, Gene Therapy, gene-changing, glycosylated, hair, hair-follicles-, inside-the-hair, ridge-national, supramolecular, tools | Comments Off

TIGET: from the laboratory to the patient’s bed – Video

16-01-2012 03:30 www.telethon.it – The San Raffaele-Telethon Institute for Gene Therapy (Hsr-Tiget) is situated in Milan and directed by Luigi Naldini. Continue reading →

Posted in Genetic Therapy | Tagged 2002-the-first, first-success, from-muscular, institute, milan, music, now-permanently, ranging-from, thalassemia-, world | Comments Off

Mucopolysaccharidoses type I; a disease targeted by Telethon research – Video

16-01-2012 03:50 www.telethon.it – Mucopolysaccharidoses type I is a rare genetic disease caused by the malfunctioning of lysosomal enzymes needed to break down molecules called glycosaminoglycans. In its most serious forms the disease causes skeleton deformities and developmental retardation as well as opaque corneas, enlarged internal organs, heart problems, lack of growth and hernias Continue reading →

Posted in Genetic Therapy | Tagged a-rare-genetic, institute, malfunctioning, mechanisms-and, milan, prospects-are, rare-genetic, serious-forms, telethon-institute, the-disease | Comments Off

Metachromatic leukodystrophy; experimentation has begun – Video

16-01-2012 03:46 www.telethon.it – Metachromatic leukodystrophy is a rare metabolic disease of genetic origin that affects the nervous system. Children are apparently normal at birth but then progressively lose all cognitive and motor faculties. The diseases mechanisms and research prospects are explained by Alessandra Biffi and Maria Sessa, researchers at the San Raffaele-Telethon Institute for gene therapy in Milan, who are carrying out the first clinical trials in the world to verify the safety and effectiveness of gene therapy for this very serious genetic disease. Continue reading →

Posted in Genetic Therapy | Tagged alessandra, and-research-, are-apparently, carrying-out, clinical-trials, cognitive-and, first, institute, maria-sessa, metachromatic, nervous, normal-at-birth, raffaele-, safety, world | Comments Off

Bella Santorum and Trisomy 18: Care has shifted for genetic disorder

Republican presidential candidate Rick Santorum stepped off the campaign trail last weekend to be with his 3-year-old daughter, Bella, who was hospitalized with pneumonia. Bella was born with a devastating genetic disorder, Trisomy 18, which means she has an extra, third copy of the 18th chromosome. Continue reading →

Posted in Genetic Therapy | Tagged 3-year-old-daughter, bella, campaign, genetic-disorder, she-has, stepped-off, stepped-off-the, the-18th, the-campaign, third-copy, trail-last, trisomy, which-means, with-his, with-pneumonia- | Comments Off

Osteoporosis Drug Complications Linked To Genetic Factors

Editor's Choice Academic Journal Main Category: Genetics Also Included In: Bones / Orthopedics Article Date: 02 Feb 2012 – 10:00 PST email to a friend printer friendly opinions Current Article Ratings: Patient / Public: 5 (1 votes) Healthcare Prof: According to a study published in the online version of the journal The Oncologist, a genetic variation that increases the risk of individuals who take bisphosphonates, developing serious necrotic jaw bone lesions, has been identified by researchers at the Columbia University College of Dental Medicine. Bisphosphonates are a common class of osteoclastic inhibitors that work by attaching to calcium in the bone and inhibiting osteoclasts, bone cells that disintegrate the bone's mineral structure. The finding opens the door for a genetic screening test to determine which individuals can take these medications safely. Continue reading →

Posted in Genetic Therapy | Tagged article, columbia, copyright, Genetics, healthcare, journal, Medical News, onj, online-, ratings, rheumatology | Comments Off

Study defines a new genetic subtype of lung cancer

“ROS1 encodes a protein that is important for cell growth and survival, and deregulation of ROS1 through chromosomal rearrangement drives the growth of tumors,” says Alice Shaw, MD, PhD, of the MGH Cancer Center – co-lead author of the paper which has been published online in the Journal of Clinical Oncology. “This finding is important because we have drugs that inhibit ROS1 and could lead to the sort of dramatic clinical response we describe in this paper.” The current findings add ROS1 to the list of genes known to drive NSCLC growth when altered – a list that includes KRAS, mutations of which account for about 25 percent of cases; EGFR, accounting for 10 to 15 percent; and ALK, rearranged in about 4 percent. Altogether, known cancer-causing genetic changes have been found in a little more than half of NSCLC tumors. Continue reading →

Posted in Genetic Therapy | Tagged a-little-more, around-the-time, california, characteristics, england, england-journal, journal, massachusetts, observation, october, patient-, time, trial, university, weight-loss | Comments Off

Researchers decipher genetic material of 48 pediatric glioblastomas

Glioblastomas grow extremely aggressively into healthy brain tissue and, moreover, are highly resistant to radiation therapy and chemotherapy. Therefore, they are regarded as the most malignant type of brain tumor Continue reading →

Posted in Genetic Therapy | Tagged all-ages, are-highly, brain-tissue, brain-tumor, currently-available, frequently-not, grow-extremely, highly-resistant, malignant-type, methods-are, most, regarded-as-the, the-most, type-, very-effective | Comments Off

Massachusetts General study defines a new genetic subtype of lung cancer

Public release date: 31-Jan-2012 [ | E-mail | Share ] Contact: Katie Marquedant kmarquedant@partners.org 617-726-0337 Massachusetts General Hospital A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ROS1 gene represent 1 to 2 percent of non-small-cell lung cancers (NSCLC), the leading cause of cancer death in the U.S. The researchers show that ROS1-driven tumors can be treated with crizotinib, which also inhibits the growth of tumors driven by an oncogene called ALK, and describe the remarkable response of one patient to crizotinib treatment Continue reading →

Posted in Genetic Therapy | Tagged aids, california, college, growth, harvard-medical, health, Human Genetics, journal, pathology, time, weight-loss | Comments Off

Study pinpoints genetic factors behind increased ALL risk in Hispanic children

Hispanic children are more likely than those from other racial and ethnic backgrounds to be diagnosed with acute lymphoblastic leukemia (ALL) and are more likely to die of their disease. Work led by St. Jude Children's Research Hospital scientists has pinpointed genetic factors behind the grim statistics Continue reading →

Posted in Genetic Therapy | Tagged a-gene-called, behind-the-grim, catastrophic, children, european, january, journal, oncology-group, racial, research, white, work | Comments Off

New genetic subtype of lung cancer defined

ScienceDaily (Jan. 31, 2012) — A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ROS1 gene represent 1 to 2 percent of non-small-cell lung cancers (NSCLC), the leading cause of cancer death in the U.S. Continue reading →

Posted in Genetic Therapy | Tagged bookmarking, california, college, health, Human Genetics, information, massachusetts, medical, Medicine, science, time, unique, united-states, university, weight-loss | Comments Off

Genetic Technologies Files Quarterly Activities Report and ASX Appendix 4C for Quarter Ended December 31, 2011

MELBOURNE, AUSTRALIA– – Genetic Technologies Limited today announced it has filed its Quarterly Activities Report and Appendix 4C for period ending December 31, 2011 in accordance with the ASX.Total cash … Continue reading →

Posted in Genetic Therapy | Tagged accordance-with, announced-it-has, appendix, asx, cash-, december, for-period, genetic, genetic-technologies, has-filed, limited, quarterly, quarterly-activities, report, with-the-asx | Comments Off

Scientists identify genetic mutations behind children's brain tumour

MONTREAL — A team of Montreal scientists has pinpointed the genetic causes behind some of the deadliest brain tumours in children, raising hopes of a “tailored” therapy that might one day save lives and spare patients horrendous side effects. Continue reading →

Posted in Genetic Therapy | Tagged a-tumours-and, colleague, copyright, DNA, england, genetic, hungary, jabado, jacek-majewski, journal, montreal, mutations, research, scientists, university | Comments Off

Medical-research cache in works in Phoenix

by Emily Gersema – Jan. 28, 2012 01:29 PM The Republic | azcentral.com A massive building near Phoenix Sky Harbor International Airport is now home to a supercomputer that one day is expected to store clinical-research reports, medical records and the decoded genetic makeup of millions of patients and their cancers. Continue reading →

Posted in Genetic Therapy | Tagged california, css, DNA, health-insurance, information, intel, maps, patients-, peirce, phoenix, privacy, project, supercomputer | Comments Off

Gene therapy is a 'disruptive science' ready for commercial development

The time for commercial development of gene therapy has come. Patients with diseases treatable and curable with gene therapy deserve access to the technology, which has demonstrated both its effectiveness and feasibility, says James Wilson, MD, PhD, Editor-in-Chief of Human … Continue reading →

Posted in Gene Therapy, Genetic Therapy, Genetics | Comments Off

Medical-research cache in works

A massive building near Phoenix Sky Harbor International Airport is now home to a supercomputer that one day is expected to store clinical-research reports, medical records and the decoded genetic makeup of millions of patients and their cancers. Continue reading →

Posted in Genetic Therapy | Tagged airport, and-the, decoded, decoded-genetic, harbor-, harbor-international, massive-building, medical-records, now-home, store-clinical-research | Comments Off

Genetic Mutation That Triggers Pancreatic Cancer Identified

Scientists at The University of Texas MD Anderson Cancer Center have identified a self-perpetuating “loop” of molecular activity that fuels pancreatic cancer by linking two signature characteristics of the disease – Kras, a gene that serves as a molecular on-off switch, but gets stuck on the “on” position when mutated, and NF-ÎºB, a protein complex that controls activation of genes. In addition … Continue reading →

Posted in Genetic Therapy | Tagged addition, anderson-, but-gets, center, disease, have-identified, linking-two, protein-complex, texas, the-disease | Comments Off

Genetic variation that raises risk of serious complication linked to osteoporosis drugs identified

ScienceDaily (Jan. 27, 2012) — New York, NY (January 26, 2012) — Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors. Continue reading →

Posted in Genetic Therapy | Tagged article, bookmarking, country, director, epidemiology, information, journal, public-health, source, technology-, trademark, university | Comments Off

New discovery paves way for genetic screening test

Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors. Continue reading →

Posted in Genetic Therapy | Tagged a-common-class, a-genetic-variation, college, columbia, columbia-university, esearchers-at-the, have-identified, raises-the-risk, risk, the-risk | Comments Off

Study Pinpoints Genetic Variation that Raises Risk of Serious Complication Linked to Osteoporosis Drugs

Posted in Genetic Therapy | Tagged a-common-class, a-genetic-variation, columbia, common-class, dental, dental-medicine, esearchers-at-the, genetic-variation, risk, take-bisphosphonates, the-risk | Comments Off